OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurophysiological signatures in Alzheimer’s disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline
Kamalini G. Ranasinghe, Jungho Cha, Leonardo Iaccarino, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 534
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity
Keith Vossel, Kamalini G. Ranasinghe, Alexander J. Beagle, et al.
JAMA Neurology (2021) Vol. 78, Iss. 11, pp. 1345-1345
Open Access | Times Cited: 181

Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology
Fernando Maestú, Willem de Haan, Marc Aurel Busche, et al.
Ageing Research Reviews (2021) Vol. 69, pp. 101372-101372
Open Access | Times Cited: 147

Iron Homeostasis Disorder and Alzheimer’s Disease
Yu Peng, Xuejiao Chang, Minglin Lang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12442-12442
Open Access | Times Cited: 112

Increased fMRI connectivity upon chemogenetic inhibition of the mouse prefrontal cortex
Federico Rocchi, Carola Canella, Shahryar Noei, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 72

Synergistic association of Aβ and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults
Jonathan Gallego-Rudolf, Alex I. Wiesman, Alexa Pichet Binette, et al.
Nature Neuroscience (2024)
Open Access | Times Cited: 17

The GLP-1 Agonist Semaglutide Ameliorates Cognitive Regression in P301S Tauopathy Mice Model via Autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization
Norhan N. Elbadawy, Muhammed A. Saad, Sara Elfarrash, et al.
European Journal of Pharmacology (2025), pp. 177305-177305
Closed Access | Times Cited: 2

Tipping the Scales: Peptide-Dependent Dysregulation of Neural Circuit Dynamics in Alzheimer’s Disease
Sam Harris, Fred Wolf, Bart De Strooper, et al.
Neuron (2020) Vol. 107, Iss. 3, pp. 417-435
Open Access | Times Cited: 137

Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer’s disease
Brendan P. Lucey, Julie K. Wisch, Anna H. Boerwinkle, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2852-2862
Open Access | Times Cited: 101

In vivo tau pathology is associated with synaptic loss and altered synaptic function
Emma M. Coomans, Deborah N. Schoonhoven, Hayel Tuncel, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 76

Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Sofia Toniolo, Arjune Sen, Masud Husain
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9318-9318
Open Access | Times Cited: 71

Tau protein spreads through functionally connected neurons in Alzheimer’s disease: a combined MEG/PET study
Deborah N. Schoonhoven, Emma M. Coomans, Ana P. Millán, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 4040-4054
Open Access | Times Cited: 34

Sex‐specific declines in cholinergic‐targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease
Dana Shulman, Serafima Dubnov, Tamara Zorbaz, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5159-5172
Open Access | Times Cited: 28

A multi-scale model explains oscillatory slowing and neuronal hyperactivity in Alzheimer’s disease
Christoffer G. Alexandersen, Willem de Haan, Christian Bick, et al.
Journal of The Royal Society Interface (2023) Vol. 20, Iss. 198
Open Access | Times Cited: 27

A Multilevel View of the Development of Alzheimer’s Disease
Jesús Ávila, George Perry
Neuroscience (2020) Vol. 457, pp. 283-293
Open Access | Times Cited: 60

Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction
Wenqiao Qiu, Rong Pan, Yong Tang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110575-110575
Open Access | Times Cited: 57

Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early-onset Alzheimer’s disease
Kamalini G. Ranasinghe, Kiwamu Kudo, Leighton Hinkley, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 744-753
Open Access | Times Cited: 50

Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer’s disease
Alex I. Wiesman, Daniel L. Murman, Rebecca A. Losh, et al.
Brain (2021) Vol. 145, Iss. 6, pp. 2177-2189
Open Access | Times Cited: 50

Stability of spectral estimates in resting-state magnetoencephalography: Recommendations for minimal data duration with neuroanatomical specificity
Alex I. Wiesman, Jason da Silva Castanheira, Sylvain Baillet
NeuroImage (2021) Vol. 247, pp. 118823-118823
Open Access | Times Cited: 46

Protopine promotes the proteasomal degradation of pathological tau in Alzheimer's disease models via HDAC6 inhibition
Sravan Gopalkrishnashetty Sreenivasmurthy, Ashok Iyaswamy, Senthilkumar Krishnamoorthi, et al.
Phytomedicine (2021) Vol. 96, pp. 153887-153887
Closed Access | Times Cited: 43

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
Deborah N. Schoonhoven, Casper T. Briels, Arjan Hillebrand, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 37

Wearable OPM‐MEG: A changing landscape for epilepsy
Mangor Pedersen, David F. Abbott, Graeme D. Jackson
Epilepsia (2022) Vol. 63, Iss. 11, pp. 2745-2753
Open Access | Times Cited: 32

Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease
Joseph Therriault, Tharick A. Pascoal, Mélissa Savard, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 659
Closed Access | Times Cited: 31

Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment
Ping‐Chung Chen, Xian Han, Timothy I. Shaw, et al.
Nature Aging (2022) Vol. 2, Iss. 10, pp. 923-940
Open Access | Times Cited: 31

Network Hyperexcitability in Early Alzheimer’s Disease: Is Functional Connectivity a Potential Biomarker?
Cornelis J. Stam, Anne M van Nifterick, Willem de Haan, et al.
Brain Topography (2023) Vol. 36, Iss. 4, pp. 595-612
Open Access | Times Cited: 16

Page 1 - Next Page

Scroll to top